Updated:
Isogenica
Isogenica is a venture capital firm headquartered in Harrogate, United Kingdom, with a website at isogenica.com. The firm operates at the intersection of...
Isogenica
Isogenica is a venture capital firm headquartered in Harrogate, United Kingdom, with a website at isogenica.com. The firm operates at the intersection of biotechnology and investment, leveraging its expertise in discovering and engineering VHH single-domain antibodies. Isogenica utilizes the world's largest synthetic VHH libraries and proprietary CIS display technology to provide customized discovery services. It serves pharmaceutical and biotechnology firms developing biotherapeutics for cancer, inflammation, and other diseases. The available facts do not specify fund sizes, portfolio companies, investment stages, or assets under management.
General information
Firm type
Venture Capital
Location
Region
Europe
Country
United Kingdom
City
Harrogate
Corporate office
Harrogate, United Kingdom
Sector focus
Frequently asked questions
Where is Isogenica headquartered?
Isogenica is headquartered in Harrogate, United Kingdom.
What technology does Isogenica use for antibody discovery?
Isogenica uses the world's largest synthetic VHH libraries and proprietary CIS display technology to provide customized discovery services.
What sectors does Isogenica serve?
Isogenica serves pharmaceutical and biotechnology firms developing biotherapeutics for cancer, inflammation, and other diseases.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: